Skip to main content
AMN logo

AMN · Amn Healthcare Services Inc

Track AMN — free
Market Cap
$1.33B
Shares
38.73M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$34.28 Open$34.32 Day$33.84–34.74 52W close$15.10–36.60 Avg vol 30d683K Short int3.2M · 8.2% float · 3.3d Short vol60% Last earningsAug 6, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 7

Up next

Next earnings call
Nov 5, 2026 Est · unconfirmed · in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 7, 2026

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 14.9 · calm Equity put/call 0.70
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +44%
above
Price vs 50-day avg +2%
above
RSI (14) 51
neutral
MACD trend Negative
52-week position 89%
near high
Momentum
relative strength
Very Strong
1-month return +4%
trailing
6-month return +68%
trailing
YTD return +118%
this year
Relative strength +54%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $34 › 200d $24 — 50d above 200d
Institutional flow Accumulating
+14% holders QoQ · +78 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
8.17% of float · ▼ -6.9% MoM · 3.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
287 holders — mid 3-yr range
Squeeze score 56
elevated · 0–100
Fundamentals
Strong
Revenue growth +5%
Y/Y
Gross margin 39%
contracting
EPS growth +36%
Y/Y
Free cash flow $233.8M
Valuation P/E 12.7
below peers
Buyback $226.7M
remaining
Balance sheet $733.1M
net debt
Quant / Vol
risk profile
Very High
Volatility 68%
annualized · 1-yr
Max drawdown −29%
past year
ATR 4.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 2 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+44% Bullish
Price vs 50-day avg
+2% Bullish
RSI (14)
51 Neutral
MACD trend
Negative Bearish
52-week position
89% Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $34 › 200d $24 — 50d above 200d
Institutional flow Accumulating
+14% holders QoQ · +78 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
8.17% of float · ▼ -6.9% MoM · 3.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
287 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $15 Now $34 · 89% Range high $37
vs 200-day avg +44% vs 50-day avg +2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AMN
Amn Healthcare Services Inc
this stock
$1.33B +117.5% +4.5% 12.7 8.2%
HCA
HCA Healthcare, Inc.
$92.69B -11.2% +7.1% 14.4 2.8%
FSNUY
Fresenius SE & Co. KGaA
$30.05B -8.0% 0.0%
THC
Tenet Healthcare Corp
$21.48B +33.8% +0.9% 10.3 3.1%
FMS
Fresenius Medical Care AG
$12.29B -4.5% +5.9% 0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
287
% held
120.9%
Net QoQ
+3.1M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
304
View
Short & Settlement
Short Interest Falling
Shares short
3.2M
Days to cover
3.3d
Change
-235.6K sh
View
Short Volume
Short vol %
60%
As of
Aug 31, 2026
Short Total
View
Fails to Deliver
FTD shares
1.3K
Value
$44.0K
As of
Aug 12, 2026
View
Off-Exchange
Off-exchange %
37.4%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Greg Gianforte
Amount
$15.0K–$50.0K
Traded
Nov 9, 2020
View
Financials
Financials
Revenue (FY)
$2.7B
Net income (FY)
$-95.7M
EPS diluted
$-2.48
View
Buybacks
Authorized
$1.4B
Remaining
$226.7M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 7, 2026
This year
12
View
Proposed Sales
Value
$114.1K
Shares
3.7K
Filed
Jun 15, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 6, 2026
View

Performance

5D 20D 120D MTD YTD
AMN -0.7% +3.9% +67.6% +1.9% +117.5%
SPY +0.5% +1.2% +13.3% +2.7% +12.5%
vs SPY -1.1% +2.6% +54.3% -0.8% +105.0%

Capital returns

Buyback program · as of Dec 31, 2025
Authorized
$1.35B
Spent (derived)
$1.12B
Remaining
$226.66M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1142750 CUSIP 001744101 13F (30d) 235 filings 225 filers Visit website Investor relations